This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mullick, J. Articles by Sahu, A. Search for Related Content PubMed PubMed Citation Articles by Mullick, J. Articles by Sahu, A.

 Previous Article  |  Next Article 

Journal of Virology, October 2005, p. 12382-12393, Vol. 79, No. 19
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.19.12382-12393.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Identification of Complement Regulatory Domains in Vaccinia Virus Complement Control Protein

Jayati Mullick, John Bernet, Yogesh Panse, Sharanabasava Hallihosur, Akhilesh K. Singh, and Arvind Sahu^*

National Centre for Cell Science, Pune University Campus, Ganeshkhind, Pune 411007, India

Received 22 March 2005/ Accepted 7 July 2005

Vaccinia virus encodes a homolog of the human complement regulators named vaccinia virus complement control protein (VCP). It is composed of four contiguous complement control protein (CCP) domains. Previously, VCP has been shown to bind to C3b and C4b and to inactivate the classical and alternative pathway C3 convertases by accelerating the decay of the classical pathway C3 convertase and (to a limited extent) the alternative pathway C3 convertase, as well as by supporting the factor I-mediated inactivation of C3b and C4b (the subunits of C3 convertases). In this study, we have mapped the CCP domains of VCP important for its cofactor activities, decay-accelerating activities, and binding to the target proteins by utilizing a series of deletion mutants. Our data indicate the following. (i) CCPs 1 to 3 are essential for cofactor activity for C3b and C4b; however, CCP 4 also contributes to the optimal activity. (ii) CCPs 1 to 2 are enough to mediate the classical pathway decay-accelerating activity but show very minimal activity, and all the four CCPs are necessary for its efficient activity. (iii) CCPs 2 to 4 mediate the alternative pathway decay-accelerating activity. (iv) CCPs 1 to 3 are required for binding to C3b and C4b, but the presence of CCP 4 enhances the affinity for both the target proteins. These results together demonstrate that the entire length of the protein is required for VCP's various functional activities and suggests why the four-domain structure of viral CCP is conserved in poxviruses.

J.M. and J.B. contributed equally to this work.

This article has been cited by other articles:

• Girgis, N. M., DeHaven, B. C., Fan, X., Viner, K. M., Shamim, M., Isaacs, S. N. (2008). Cell Surface Expression of the Vaccinia Virus Complement Control Protein Is Mediated by Interaction with the Viral A56 Protein and Protects Infected Cells from Complement Attack. J. Virol. 82: 4205-4214 [Abstract] [Full Text]  
• Hocking, H. G., Herbert, A. P., Kavanagh, D., Soares, D. C., Ferreira, V. P., Pangburn, M. K., Uhrin, D., Barlow, P. N. (2008). Structure of the N-terminal Region of Complement Factor H and Conformational Implications of Disease-linked Sequence Variations. J. Biol. Chem. 283: 9475-9487 [Abstract] [Full Text]  
• Yadav, V. N., Pyaram, K., Mullick, J., Sahu, A. (2008). Identification of Hot Spots in the Variola Virus Complement Inhibitor (SPICE) for Human Complement Regulation. J. Virol. 82: 3283-3294 [Abstract] [Full Text]  
• Rooijakkers, S. H. M., Milder, F. J., Bardoel, B. W., Ruyken, M., van Strijp, J. A. G., Gros, P. (2007). Staphylococcal Complement Inhibitor: Structure and Active Sites. J. Immunol. 179: 2989-2998 [Abstract] [Full Text]  
• Kuttner-Kondo, L., Hourcade, D. E., Anderson, V. E., Muqim, N., Mitchell, L., Soares, D. C., Barlow, P. N., Medof, M. E. (2007). Structure-based Mapping of DAF Active Site Residues That Accelerate the Decay of C3 Convertases. J. Biol. Chem. 282: 18552-18562 [Abstract] [Full Text]  
• Singh, A. K., Mullick, J., Bernet, J., Sahu, A. (2006). Functional Characterization of the Complement Control Protein Homolog of Herpesvirus Saimiri: ARG-118 IS CRITICAL FOR FACTOR I COFACTOR ACTIVITIES. J. Biol. Chem. 281: 23119-23128 [Abstract] [Full Text]  
• Spiller, O. B., Mark, L., Blue, C. E., Proctor, D. G., Aitken, J. A., Blom, A. M., Blackbourn, D. J. (2006). Dissecting the Regions of Virion-Associated Kaposi's Sarcoma-Associated Herpesvirus Complement Control Protein Required for Complement Regulation and Cell Binding.. J. Virol. 80: 4068-4078 [Abstract] [Full Text]  
• Liszewski, M. K., Leung, M. K., Hauhart, R., Buller, R. M. L., Bertram, P., Wang, X., Rosengard, A. M., Kotwal, G. J., Atkinson, J. P. (2006). Structure and Regulatory Profile of the Monkeypox Inhibitor of Complement: Comparison to Homologs in Vaccinia and Variola and Evidence for Dimer Formation. J. Immunol. 176: 3725-3734 [Abstract] [Full Text]